Nestlé dives deeper into biotech and creates new centre

Nestlé is strengthening its R&D expertise in biotechnology and has created a new centre for deep tech, to boost its innovation pipeline and increase efficiency in research, innovation and operations.

Enhanced R&D expertise in biotechnology and clinical research is designed to lead to new nutritional solutions. This is set to boost the company’s pipeline of solutions for maternal, early life and medical nutrition, and support new growth platforms such as healthy longevity, women’s health and weight management. Science-based solutions will also be used for the company’s pet care business, including pet therapeutics. New capabilities will include developments in its screening assays, precision fermentation and clinical research program. The investment is also set to drive advances in precision nutrition and the development of new generations of bio-actives and biotics including post- and synbiotics.

The centre will screen, test and develop new generations of sensors, robots, coding systems, high-performing AI and virtual/mixed reality solutions to increase efficiency in research, innovation and operations. New technologies will enable the development of smart coffee machines, innovative solutions for precision nutrition, self-controlling equipment and new solutions for dynamic quality assurance. 

The centre will be officially opened in the first half of 2026, at the existing facilities of the Nestlé System Technology Center in Orbe, Switzerland.

Stefan Palzer, CTO of Nestlé S.A., said: “We continue to transform our R&D organisation to embrace science and technology trends and to seize current and future growth opportunities. The industry-leading biotechnology capabilities will deliver new ingredients with clinically proven bio-efficacy for precision nutrition for people and pets along their entire lifespan. The upscaling of our unique capabilities in deep tech are key to maximise efficiency in innovation and operations. And all of this is powered by a leaner and more agile R&D organisation.”

Image credit: iStock.com/RgStudio